pseudoviru
recombin
viral
particl
corebackbon
envelop
protein
deriv
differ
moreov
gene
insid
pseudoviru
usual
alter
modifi
unabl
produc
surfac
protein
addit
plasmid
stabl
cell
line
express
surfac
protein
need
make
pseudovirus
capabl
infect
suscept
cell
replic
round
infect
host
compar
wt
virus
pseudovirus
safe
handl
biosafeti
level
bsl
usual
easier
manipul
nevertheless
conform
structur
pseudovir
surfac
protein
bear
high
similar
nativ
viral
protein
surfac
protein
effect
mediat
viral
entri
host
cell
therefor
pseudovirus
wide
use
studi
cellular
receptor
viru
well
develop
evalu
addit
data
vitro
antivir
assay
vivo
biodistribut
analys
found
correl
well
result
gener
use
live
wt
pseudovirus
usual
engin
carri
report
gene
much
easier
perform
quantit
analys
virus
wt
number
cell
shown
directli
proport
report
gene
express
report
gene
usual
encod
either
enzym
fluoresc
protein
option
particular
strength
weak
specif
chemiluminesc
assay
usual
lower
background
sensit
data
acquisit
analys
assay
expens
contrast
assay
use
floresc
protein
green
fluoresc
protein
cheaper
easier
oper
vitro
vivo
system
howev
less
sensit
may
higher
review
provid
updat
develop
applic
pseudovir
system
discuss
challeng
technic
issu
packag
system
wide
use
pseudoviru
packag
system
make
packag
system
hiv
gene
select
clone
dna
vector
specif
plasmid
use
vector
strategi
aim
minim
viral
gene
recombin
therebi
reduc
possibl
revers
wt
viru
tabl
list
current
use
system
origin
system
compris
envelop
plasmid
backbon
plasmid
ie
env
gene
sequenc
destroy
howev
system
ideal
viral
yield
usual
low
improv
made
addit
sequenc
better
report
gene
express
specif
research
group
insert
report
gene
firefli
luciferas
fluc
env
nef
produc
addit
also
gener
carri
function
nef
cmv
promot
drive
report
use
optim
backbon
envelop
protein
express
plasmid
group
succeed
produc
sever
hiv
pseudovirus
carri
envelop
protein
ebov
marv
lasv
middl
east
respiratori
rabi
viru
rv
chikungunya
viru
nipah
viru
niv
yield
pseudovirus
construct
optim
system
improv
compar
pseudovirus
construct
hiv
system
usual
compris
packag
plasmid
transfer
plasmid
contain
report
gene
plasmid
specif
system
made
split
backbon
separ
pack
transfer
plasmid
packag
plasmid
express
gag
pol
protein
transfer
plasmid
contain
element
need
hiv
revers
transcript
integr
packag
well
multipl
clone
site
report
gene
control
heterogen
plasmid
made
vector
carri
envelop
gene
driven
cmv
promot
hiv
system
base
system
rev
protein
express
addit
separ
plasmid
specif
system
compris
packag
plasmid
express
gag
pol
protein
second
packag
plasmid
encod
rev
plasmid
produc
wt
envelop
protein
transfer
plasmid
system
report
differ
group
yet
comparison
made
among
differ
system
safeti
effici
group
abl
drastic
improv
viral
yield
system
safeti
issu
hiv
pseudovir
system
observ
hiv
caus
agent
aid
could
rais
safeti
concern
investig
employ
siv
vector
develop
similar
system
explor
potenti
use
gene
therapi
siv
packag
system
construct
base
viral
genom
sandrin
et
al
cotransfect
cell
packag
vector
transfer
vector
express
envelop
protein
pseudovirus
demonstr
high
transduct
effici
primari
blood
lymphocyt
cell
deriv
either
human
investig
also
use
fluoresc
protein
vector
packag
vector
determin
factor
contribut
intracellular
cell
surfac
format
variou
target
virus
yield
moor
et
al
use
siv
packag
system
construct
pseudotyp
sever
acut
respiratori
syndrom
coronaviru
screen
theori
pseudoviru
may
safer
hiv
counterpart
well
resist
preexist
neutral
antibodi
vesicular
stomat
viru
vsv
murin
leukemia
viru
mlv
gibbon
ape
leukemia
viru
pseudotyp
felin
endogen
viru
envelop
glycoprotein
pseudoviru
demonstr
augment
transduct
effici
blood
cell
human
primat
report
indic
pseudovirus
facilit
preclin
studi
antivir
screen
gene
therapi
studi
felin
immunodefici
system
also
found
promis
method
pseudoviru
product
medina
et
al
use
transfer
vector
packag
plasmid
fiv
construct
pseudotyp
ebov
compar
ebov
pseudoviru
packag
hiv
system
ebov
pseudoviru
packag
fiv
system
higher
titer
appar
mutat
gp
protein
contribut
higher
pseudovir
titer
better
safeti
result
use
fiv
packag
system
backbon
investig
develop
variou
pseudotyp
virus
vsv
rv
ross
river
viru
viral
particl
found
valuabl
studi
viral
receptor
recognit
gene
transduct
vsv
packag
system
versatil
tool
make
pseudotyp
virus
system
advantag
stringent
select
envelop
protein
result
viru
may
manipul
laboratori
earli
studi
jointli
employ
vsv
second
viru
coinfect
cell
result
pseudotyp
viru
carri
core
vsv
envelop
protein
deriv
stillman
et
al
first
clone
vsv
genom
plasmid
make
stabl
subsequ
use
gener
pseudovirus
carri
heterogen
variou
report
gene
success
insert
plasmid
facilit
easi
exampl
pseudoviru
system
list
tabl
notabl
vsv
packag
system
use
make
pseudoviru
may
residu
vsv
viru
mix
pseudoviru
therebi
complic
neutral
assay
use
produc
result
prefer
amount
vsv
minim
howev
excess
vsv
believ
interf
assay
treatment
pseudoviru
prepar
vsv
neutral
antibodi
could
consid
use
futur
assay
mlv
packag
system
also
call
retrovir
system
commonli
use
make
pseudovirus
tabl
list
pseudovirus
packag
mlv
system
report
literatur
earli
work
witt
colleagu
show
use
vsv
infect
cell
mlv
packag
abl
harvest
pseudoviru
use
neutral
antibodi
sinc
genom
mlv
split
part
one
encod
contain
report
gene
gene
set
clone
plasmid
gener
highli
effici
mlv
packag
improv
stabil
system
investig
establish
sever
cell
line
confirm
stabl
transfect
express
murin
leukemia
viru
may
actual
better
choic
hiv
packag
system
case
exampl
studi
entri
cell
cosset
et
al
compar
mlv
hiv
system
found
former
effici
aforement
pseudoviru
packag
system
alway
success
gener
certain
type
pseudovirus
case
altern
revers
genet
report
exampl
hu
et
al
prepar
pseudotyp
dengu
viru
denv
type
use
hiv
system
titer
insuffici
howev
use
revers
genet
report
gene
insert
viral
genom
construct
pseudotyp
flaviviru
success
exampl
use
revers
genet
includ
denv
west
nile
viru
wnv
japanes
enceph
viru
subsequ
use
develop
neutral
antibodi
assay
specif
pierson
et
al
cotransfect
cell
plasmid
contain
subreplicon
report
gene
capsid
prme
gener
pseudotyp
sobrinho
et
al
develop
pseudotyp
base
method
use
pierson
moreov
qing
et
al
construct
pseudotyp
semliki
forest
venezuelan
equin
enceph
electropor
pseudovirus
prove
use
screen
antivir
gener
subcellular
local
viral
packag
matur
may
larg
dictat
pseudovir
titer
special
envelop
protein
local
surfac
cell
membran
rel
easi
gener
pseudovirus
use
either
hiv
vsv
packag
system
report
filoviru
contrast
envelop
protein
local
membran
organel
eg
endoplasm
reticulum
golgi
complex
bunyaviru
yellow
fever
viru
difficult
obtain
pseudoviru
furthermor
envelop
protein
local
section
membran
nearli
imposs
form
previou
studi
suggest
local
envelop
protein
close
relat
structur
particularli
transmembran
portion
envelop
protein
therefor
effort
made
modifi
envelop
protein
improv
pseudoviru
yield
exampl
truncat
cytoplasm
region
envelop
protein
possibl
reduc
intracellular
accumul
envelop
protein
therebi
facilit
assembl
envelop
protein
vector
core
addit
replac
cytoplasm
tail
envelop
protein
envelop
tail
vsv
mlv
also
improv
pseudoviru
yield
furthermor
retarget
envelop
protein
intracellularli
anoth
method
potenti
improv
pseudovir
howev
note
truncat
cytoplasm
region
envelop
protein
may
unwant
consequ
alter
nativ
structur
surfac
domain
could
impact
function
antigen
phenotyp
pseudoviru
express
level
envelop
protein
could
significantli
affect
effici
pseudoviru
assembl
appar
increas
express
envelop
protein
abl
substanti
improv
pseudoviru
titer
nie
et
al
report
express
level
wt
protein
cell
low
pseudotyp
howev
codon
optim
gene
drastic
improv
yield
pseudotyp
data
indic
express
envelop
protein
highli
effici
express
vector
could
increas
pseudovir
titer
choic
packag
system
significantli
affect
viral
yield
may
need
optim
basi
temperton
et
al
compar
mlv
hiv
system
found
pseudoviru
prepar
mlv
better
one
prepar
hiv
packag
system
use
cell
success
use
mlv
packag
system
gener
pseudotyp
influenza
cosset
et
al
reach
conclus
pseudotyp
lasv
moreov
experi
pseudotyp
lasv
packag
vsv
system
higher
titer
produc
use
hiv
system
furthermor
vsv
system
abl
incorpor
hantaviru
glycoprotein
fail
packag
hiv
nonetheless
group
develop
modif
hiv
packag
system
could
improv
pseudovir
yield
specif
backbon
plasmid
develop
lab
superior
packag
condit
also
drastic
influenc
pseudoviru
yield
hiv
packag
system
pseudoviru
titer
could
increas
optim
packag
cell
transfect
reagent
ratio
absolut
amount
plasmid
dna
use
vsv
packag
system
pseudoviru
titer
could
improv
optim
harvest
pseudotyp
human
respiratori
syncyti
viru
made
use
hiv
packag
system
haid
et
al
cotransfect
plasmid
cell
use
transfect
reagent
pei
optim
transfect
condit
ad
sodium
butyr
hour
posttransfect
induc
gene
pseudovirus
need
special
enzymesreag
product
optim
titer
scott
et
al
optim
product
equin
virus
via
addit
exogen
neuraminidas
clostridium
perfringen
allow
releas
nascent
pseudoviru
observ
indic
packag
condit
optim
improv
pseudoviru
yield
basi
pseudovirus
wide
use
conduct
vitro
studi
interact
viru
host
also
proven
use
vivo
studi
particularli
studi
mechan
viral
infect
well
lab
use
pseudotyp
rv
carri
report
gene
establish
vivo
imag
model
mice
mous
model
use
studi
viral
tissu
tropism
dynam
chang
also
establish
pseudotyp
ebov
mous
model
ebov
pseudovirus
mainli
detect
thymu
spleen
follow
viral
infect
reveal
pseudotyp
ebov
wt
ebov
tissu
group
also
use
pseudotyp
marv
small
anim
model
investig
viral
antibodi
neutral
assay
base
pseudovirus
wide
use
particularli
analys
virul
virus
would
otherwis
need
handl
laboratori
compar
tradit
assay
report
assay
demonstr
good
correl
wt
assay
assay
usual
procedur
fewer
amount
serum
sampl
wilkinson
et
al
compar
platform
technolog
assay
antibodi
ebov
neutral
assay
use
wt
viru
found
best
assay
includ
method
base
wt
vsv
pseudotyp
neutral
elisa
lentivir
platform
notabl
duehr
j
et
al
indic
glycoprotein
monoclon
antibodi
could
neutral
protect
pseudotyp
nonneutr
wt
recent
pseudovir
system
also
explor
analysi
cytotox
adcc
activ
might
better
choic
use
target
cell
transfect
dna
plasmid
success
employ
pseudoviru
adcc
assay
may
surfac
protein
pseudoviru
larg
retain
nativ
conform
follow
infect
portion
protein
remain
surfac
target
cell
adcc
assay
target
cell
first
infect
pseudoviru
follow
addit
monoclon
antibodi
modifi
jurkat
cell
effector
cell
monoclon
antibodi
adcc
activ
fab
portion
bind
target
cell
fc
bind
activ
modifi
jurkat
cell
engin
stabli
express
fc
receptor
high
affin
variant
addit
luciferas
control
nfat
respons
variou
studi
carri
use
pseudovirus
screen
compound
includ
lasv
ebov
marv
niv
influenza
wang
et
al
use
pseudotyp
marv
influenza
lasv
screen
compound
approv
us
food
drug
administr
treat
medic
condit
found
compound
broad
rang
antivir
activ
marv
influenza
use
pseudoviru
elshabrawi
et
al
abl
select
small
molecul
compound
broad
spectrum
antivir
activ
marv
hendra
viru
niv
investig
author
reveal
compound
prevent
viral
entri
cell
block
cathepsin
enzym
besid
small
molecul
pseudovirus
also
use
screen
herbal
medicin
potenti
antivir
technic
challeng
associ
pseudovir
system
describ
sever
remain
issu
also
worth
mention
definit
pseudovirus
contain
membraneenvelop
protein
wt
viru
membraneenvelop
protein
larg
mediat
viral
entri
fashion
like
wt
viru
virus
replic
round
may
alway
induc
pathogenesi
wt
counterpart
therefor
result
assay
use
pseudotyp
virus
compar
valid
wt
assay
remain
golden
addit
viru
shape
may
influenc
suitabl
construct
correspond
pseudotyp
viru
exampl
mlv
hiv
siv
spheric
virus
wherea
vsv
therefor
pattern
glycoprotein
distributionconformationdens
pseudotyp
viru
may
reflect
natur
state
envelop
protein
wt
virus
eg
filovirus
also
good
practic
compar
variou
packag
system
inde
investig
sometim
use
packag
system
simultan
prepar
pseudovirus
compar
result
pseudoviru
one
packag
vsv
notabl
bilska
et
al
show
viru
prepar
give
rise
low
level
viru
highlight
need
perform
rigor
test
viru
initi
work
pseudoviru
prepar
lower
success
gener
pseudovir
particl
mainli
limit
envelop
virus
effort
made
determin
whether
nonenvelop
virus
could
also
effect
pseudotyp
author
compet
interest
